4D Molecular Therapeutics(FDMT.US) Officer Sells US$45,045 in Common Stock

$4D Molecular Therapeutics(FDMT.US)$ Officer Bizily Scott sold 1,750 shares of common stock on Apr 16, 2024 at an average price of $25.74 for a total value of $45,045.Source: Announcement What is stat

moomoo NewsApr 18 21:31 ET

4D Molecular Therapeutics Is Maintained at Outperform by RBC Capital

4D Molecular Therapeutics Is Maintained at Outperform by RBC Capital

Dow JonesApr 15 13:23 ET

RBC Capital Maintains Outperform on 4D Molecular Therapeutics, Raises Price Target to $40

RBC Capital analyst Luca Issi maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Outperform and raises the price target from $35 to $40.

BenzingaApr 15 13:13 ET

4D Molecular Therapeutics New Overweight at Barclays on Genetic Medicine Platform

Seeking AlphaApr 15 12:22 ET

RBC Capital Reaffirms Their Buy Rating on 4D Molecular Therapeutics (FDMT)

TipRanksApr 15 06:55 ET

Express News | 4D Molecular Therapeutics Inc : Barclays Initiates Coverage With Overweight Rating and Target Price $45

Moomoo 24/7Apr 15 06:31 ET